GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Apotea AB (publ) APOTEA.ST · SEK

Consumer Staples · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

105.60

+1.25%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Apotea AB (publ)

Its shares trade on Nasdaq Stockholm under the ticker APOTEA.ST. It has been listed since 6 December 2024. In the fiscal year to 31 December 2025, it reported revenue of SEK 7.20bn and net income of SEK 228.7m. At that date it held total assets of SEK 1.98bn and shareholders' equity of SEK 844.0m.

Apotea AB engages in the provision of an online pharmacy that sells a range of both non-prescription and prescription drugs. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2024-12-06. The firm provides wholesale trade of cosmetics, general drugs and other pharmacy-related products through its website and local pharmacies.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Listed since
6 Dec 2024
Employees
725
Website
apotea.se ↗

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Apotea AB has a strong online pharmacy platform for selling both non-prescription and prescription drugs.
  • The company is headquartered in Stockholm with 725 employees supporting operations.
  • Apotea AB offers wholesale trade of cosmetics, general drugs, and pharmacy-related products.

Weaknesses

  • The company's IPO is scheduled for 2024-12-06, indicating a recent market entry.
  • Apotea AB's operations are limited to online and local pharmacies, which may restrict market reach.
  • The company provides pharmacy-related products but lacks details on specific product range or market share.

Opportunities

  • The online pharmacy market is growing, offering potential for increased sales and market share.
  • Apotea AB can expand its wholesale trade to new regions or product categories.
  • The IPO on 2024-12-06 may attract investment for further growth and development.

Threats

  • The online pharmacy industry faces regulatory challenges and strict compliance requirements.
  • Competition from established online and physical pharmacy retailers could impact market position.
  • The company's reliance on a single market (Stockholm) may expose it to regional economic fluctuations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.